Diligence memo · auto-generated · as of July 2, 2026

Curacel

Curacel has raised $450K over 1 round; too few niche peers to rank its valuation yet.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Curacel operates in Insurance, based in London, United Kingdom. AI-Powered Infrastructure for Insurance & Healthcare

Sub-sector tags: AI, B2B, Healthcare IT, Insurance, SaaS, ai/ml, insurance.

Capital & rounds (filed)filed

Curacel has raised $450K in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).

Largest single filing: $450K on 2021-03-31.

Most recent recorded round closed around 2021-03-31.

Valuation (modeled)modeled

Provath models Curacel at approximately $7.5M (range $300K–$68M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Too few comparable companies in this niche to rank the valuation fairly yet.

Financing rhythm & timingmixed

Last raise 5.3 yr ago; this sector typically re-raises about every 12 months.

Only one round on record and long silent — often defunct, acquired, or gone quiet.

Comparablesmixed

Capital scale ranks ahead of 73% of Insurance peers (146 compared).

Modeled value ranks above 75% of those peers.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.